Icaritin soft capsules

DRUG3 trials

Sponsors

Zhejiang Cancer Hospital, Zhiyong Huang, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

Hepatocellular CarcinomaRFSUnresectable Hepatocellular Carcinoma

Phase 1

Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma

Not yet recruitingNCT06896396

Zhiyong HuangUnresectable Hepatocellular Carcinoma

Start: 2025-04-01End: 2028-02-01Target: 60Updated: 2025-03-26

Phase 2

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Zhejiang Cancer HospitalHepatocellular Carcinoma

Start: 2023-07-31End: 2025-12-31Target: 20Updated: 2023-06-15

Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence

Active, not recruitingNCT07328828

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityRFS

Start: 2024-03-01End: 2026-06-30Target: 20Updated: 2026-01-09